The Planning Committee has determined that there is a strong need for this conference based on the clinical and public health significance of atrial fibrillation as the most common cardiac arrhythmia and a growing epidemic, as well as rapid advances in our understanding of the mechanisms of and treatment options for this major public health problem. This three-day symposium is designed to meet the following objectives:
- Discuss the current scientific advances in pathophysiology and technology for the diagnosis and treatment of atrial fibrillation and atrial fibrillation related stroke.
- Discuss and integrate the application of current and evolving pharmacological and nonpharmacological therapies, and technologies related to atrial fibrillation and atrial fibrillation-related stroke.
- Identify the appropriate treatment options to improve patient outcomes.
- Provide appropriate care and counsel for patients and their families.
This symposium has been designed to meet the educational needs of cardiologists, internists, fellows, nurses, and technicians involved in the care of patients with atrial fibrillation. The scientific basis for, clinical experience with and limitations of new and existing therapies for atrial fibrillation and prevention of atrial fibrillation-related stroke will be explored. In addition to formal lectures, recorded case presentations, case discussions, focused mini-symposia and faculty-audience interactions using an audience response system will be used to highlight the current state of scientific knowledge in areas of major importance to clinicians. The faculty is selected to provide the highest quality teaching and access to the most current scientific information from leading international experts in the field.
Physician Continuing Statement:
Accreditation Statement: This activity has been planned and implemented in accordance with the essential areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Postgraduate Institute for Medicine and AEI dba Advanced Medical Education Inc. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation: The Postgraduate Institute for Medicine designates this live activity for a maximum of 27.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
European Continuous Medical Education Credit: AMA PRA Category 1 Credit(s)™ claimed by physicians attending live events certified and organized in the United States for AMA PRA Category 1 Credit(s)™ can be claimed through the agreement on mutual recognition of credits between UEMS and AMA, considered as being equal to European Continuous Medical Education Credits (ECMEC©) granted by the UEMS. One AMA PRA Category 1 Credit™ is equivalent to (1) hour of European EACCME credit (ECMEC©, therefore up to 27.75 EECMEC© Credits are available.
Nursing Continuing Education
Accreditation Statement: Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurse Credentialing Center’s Commission on Accreditation.
Credit Designation-: This educational activity for 26.7 contact hours is provided by Postgraduate Institute for Medicine.
Nursing Educational Objective
After completing this activity, the participant should be able to:
· Provide appropriate care and counsel for patients and their families
A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be emailed to you within three weeks.